
US government plans to purchase large supply of COVID-19 treatment sotrovimab for winter surge
Fox News
The United States government announced plans to purchase sotrovimab, an investigational monoclonal antibody used for the early treatment of COVID-19
Sotrovimab was granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA) in May 2021. Under the EUA, the investigational single-dose intravenous infusion SARS-CoV-2 monoclonal antibody can be used to treat mild-to-moderate COVID-19 in adults and children 12 years of age and older, who tested positive for COVID-19, and are at high risk for developing severe cases of COVID-19 leading to hospitalization or death, according to the FDA website.
"It gives patients a real heads start in fighting off the virus," Bart Murray, Vice President of COVID Therapeutics at GSK told Fox news in an interview.













